Join Our Mailing List:
 
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
310-841-2600
Featured Events
View All Events
Veronica Jones, M.D.
Research performed at: City of Hope Comprehensive Cancer Center
Specialty/Research Area: Breast Cancer
Award Year: 2018
Career Summary: Dr. Veronica Jones is an Assistant Professor in the Department of Surgery, Division of Surgical Oncology at City of Hope (Duarte, CA).  She primarily treats malignant and benign breast disease.  Her primary research focus is developing novel imaging techniques to detect aggressive biology and guide treatment in breast cancer.  She is particularly interested in identifying the link between what is visualized on imaging and the molecular pathways associated with chemoresistance in luminal type breast cancer.  Dr. Jones received her Bachelor of Arts degree in Cultural Anthropology with a focus on medicine from Stanford University in Stanford, CA (2004).  From there she received a Doctor of Medicine from Meharry Medical College in Nashville, TN (2008) and then completed General Surgical Residency at Baylor University Medical Center in Dallas, TX (2013) where she was Chief Resident of the Year.  She furthered her training with a fellowship in Breast Surgical Oncology at Emory University in Atlanta, GA (2014).

In addition to her STOP CANCER Award, she is also principal investigator on a NIH U01 Minority Supplement Grant investigating proteomic pathways associated with aggressive type luminal breast cancer (2017-2019).  Additionally, she is principal investigator on several City of Hope sponsored studies developing novel imaging techniques to detect breast cancer.

Year STOP CANCER Award was received: 2018 STOP CANCER Member Seed Grant (Breast/Gynecological) 
 
Description of the research performed: Luminal breast cancer is generally a more favorable type of breast cancer; however, certain subtypes prove to be more aggressive and behave similarly to triple negative breast cancer.  This projects aims to identify the molecular pathways associated with aggressive type luminal breast cancer and investigate how these molecular pathways translate into changes on breast magnetic resonance imaging.

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2018 STOP CANCER. All Rights Reserved. | Privacy Policy